Podiatrists in Pittsburg, KS Accepting Medicare

3 Podiatrists found. Showing 1 - 3

Wilde Foot & Ankle Clinic Pa Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 407 E Centennial Dr, Pittsburg, KS 66762 Phone: 620-231-5940    Fax: 620-231-5948

Dr. Corin Q Wilde, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 407 E Centennial Dr, Pittsburg, KS 66762 Phone: 620-231-5940    Fax: 620-231-5948

Dr. Richard Paul Hudson, D.P.M. Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 2309 Tucker Terrace, Pittsburg, KS 66762 Phone: 620-231-4010    Fax: 620-231-4010

News Archive

Function and regeneration of dendritic cells impaired in COVID-19

A group of researchers from Germany has investigated and analyzed circulating dendritic cells and monocyte subsets in 65 hospitalized COVID-19 patients with mild to severe presentations of the infection. A variety of patients were included in their study, from those who exhibited minor signs of acute disease to convalescents, as well as healthy controls

Bacteria use host's immune response to their competitive advantage

Millions of bacteria live within the recesses of our noses and upper respiratory tracts, waiting for a chance to infiltrate and infect. But long before these bacteria break through our immune defenses, they must first compete against other bacterial species to colonize the mucus-lined surfaces of our noses.

Study provides evidence that oral immunotherapy may be possible cure for peanut allergy

Allergy immunotherapy company Prota Therapeutics Pty Ltd is pleased to announce results from a follow up study of the probiotic and peanut immunotherapy (PPOIT) treatment which it has licensed from the Murdoch Childrens Research Institute, demonstrating long-lasting tolerance effects of treatment more than four years after the original study ended.

Antibody therapeutics targeting GPCRs to be developed by alliance between MorphoSys and Heptares

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.

Study defies decades-old patient eligibility guidelines for bariatric surgery

Weight-loss surgery has long been shown to improve or resolve diabetes, reduce heart attacks and stroke and produce significant weight loss, but the operation has generally been restricted by health insurers to people with severe obesity, which means about 75 to 100 pounds overweight or a body mass index (BMI) of 35 or higher.

Read more Medical News

› Verified 1 days ago